Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) — Cash Flow Reinvestment Rate
Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) has a Cash Flow Reinvestment Rate of 16.27x as of December 2023, reinvesting CN¥602.32 Million (capex CN¥70.15 Million plus investments CN¥-532.17 Million) from operating cash flow of CN¥37.03 Million. Explore 301281 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shandong Keyuan Pharmaceutical Co. Ltd. A Cash Flow Reinvestment Rate (2021–2023)
Historical reinvestment intensity for Shandong Keyuan Pharmaceutical Co. Ltd. A across 3 annual periods. Also explore Shandong Keyuan Pharmaceutical Co. Ltd. (301281) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Shandong Keyuan Pharmaceutical Co. Ltd. A (2021–2023)
Year-by-year capital reinvestment analysis for Shandong Keyuan Pharmaceutical Co. Ltd. A. For live market cap and broader valuation context, see Shandong Keyuan Pharmaceutical Co. Ltd. market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 16.27x | CN¥602.32 Million | CN¥37.03 Million | CN¥70.15 Million | ▲ +5958.1% |
| 2022 | 0.27x | CN¥31.11 Million | CN¥115.86 Million | CN¥31.11 Million | ▼ -30.8% |
| 2021 | 0.39x | CN¥20.19 Million | CN¥52.02 Million | CN¥20.19 Million | — |